Company Profile
Area of Focus:
Therapeutic
Stage:
Preclinical
Contact Info:
12635 E. Montview Blvd.
Suite 131
Aurora, CO 80045
Tel: 720 859 4056
Fax: 720 859 4067
Email:
info@taligentherapeutics.com
Web:
http://www.taligentherapeutics.com
Taligen Therapeutics
Taligen Therapeutics is focused on the discovery and development of novel protein therapeutics that modulate the alternative pathway of the complement system to treat a wide range of inflammatory conditions and diseases. The company's lead therapeutic candidates are monoclonal antibodies and recombinant fusion proteins that target key factors in the alternative pathway, which Taligen's founders have validated as an important amplification loop in the inflammation process.